JAZZ PHARMACEUTICAL (J7Z BE) stock market data APIs
€119.1034
0(0%)
as of November 14, 2025
Try our APIs with
free plan!
JAZZ PHARMACEUTICAL Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for J7Z.BE.
Prev. Close
119.1034
Open
119.1034
High
119.1034
Low
119.1034
52 wk Range
86.72-136.6
Market Cap
6 680 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get JAZZ PHARMACEUTICAL data using free add-ons & libraries
Get JAZZ PHARMACEUTICAL Fundamental Data
JAZZ PHARMACEUTICAL Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-05
- EPS/Forecast: 5.85
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
JAZZ PHARMACEUTICAL News
New
Is Jazz Pharmaceuticals a Hidden Opportunity After 14% Climb and Expansion in 2025?
Wondering if Jazz Pharmaceuticals might be a hidden bargain or riding too high? Let’s take a closer look at what investors should know about its current value. The stock has climbed 7.6% in the past...
The Top 5 Analyst Questions From Jazz Pharmaceuticals’s Q3 Earnings Call
Jazz Pharmaceuticals delivered a quarter that exceeded Wall Street’s expectations, with management attributing results to robust demand for Xywav and Epidiolex, as well as the swift and successful l...
Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-orient...
Jazz Pharmaceuticals Showcases New Clinical and Translational Data for Modeyso™ (dordaviprone) in H3 K27M-mutant Diffuse Midline Glioma at SNO 2025
Data highlight continued progress in Jazz's brain tumor research and demonstrate the company's commitment to advancing treatment options for patients with rare and aggressive brain tumors For U.S. me...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
